Gottlieb: Epidiolex Approval Covers One Specific Cannabidiol Medication, Not Marijuana

The approval for the GW Pharmaceuticals drug covers the treatment of Lennox-Gastaut syndrome and Dravet syndrome, two forms of rare and severe childhood epilepsy – the US agency was quick to clarify what the approval did not cover, chiefly marijuana.